Immetacyte Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Immetacyte General Information
Description
Developer of tumor-infiltrating lymphocyte therapy based in Manchester, United Kingdom. The company specializes in providing patient-specific immunotherapy and uses T cells isolated from the patient's cancer that are cancer specific, allowing the patient's own T cells to fight their cancer.
Contact Information
Website
www.immetacyte.comCorporate Office
- 48 Grafton Street
- Manchester M13 9XX
- England, United Kingdom
Corporate Office
- 48 Grafton Street
- Manchester M13 9XX
- England, United Kingdom
Immetacyte Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Immetacyte Signals
Immetacyte FAQs
-
When was Immetacyte founded?
Immetacyte was founded in 2008.
-
Where is Immetacyte headquartered?
Immetacyte is headquartered in Manchester, United Kingdom.
-
What is the size of Immetacyte?
Immetacyte has 1 total employees.
-
What industry is Immetacyte in?
Immetacyte’s primary industry is Drug Discovery.
-
Is Immetacyte a private or public company?
Immetacyte is a Private company.
-
What is the current valuation of Immetacyte?
The current valuation of Immetacyte is .
-
What is Immetacyte’s current revenue?
The current revenue for Immetacyte is .
-
When was Immetacyte acquired?
Immetacyte was acquired on 02-Mar-2020.
-
Who acquired Immetacyte?
Immetacyte was acquired by Instil Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process